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Background: Polyhydroxyalkanoates (PHAs) are a group of biodegradable plastics that are produced by a wide
variety of microorganisms, mainly as a storage intermediate for energy and carbon. Polyhydroxybutyrate (PHB) is a
short-chain-length PHA with interesting chemical and physical properties. Large scale production of PHB is not
wide-spread mainly due to the downstream processing of bacterial cultures to extract the PHB. Secretion of PHB
from Escherichia coli could reduce downstream processing costs. PHB are non-proteinaceous polymers, hence
cannot be directly targeted for secretion. Phasin, PhaP1, is a low molecular weight protein that binds to PHB,
reducing PHB granule size. In this study PHB is indirectly secreted with PhaP1 from E. coli via type I secretion using
HlyA signal peptides.
Results: This study demonstrated the successful secretion of phasin and phasin bound PHB outside of the cell and
into the culture medium. The secretion of PHB was initiated between 24 and 48 h after induction. After 48 h of
culturing, 36% of the total PHB produced in the secreting strain was collected in the secreted fraction and 64%
remained in the internal fraction. To further support the findings of this study, the PHB secretion phenomenon
was observed using SEM.
Conclusions: From this study, the ability to use type I secretion to: 1) secrete phasin and 2) successfully secrete
PHB has been shown.
Keywords: Polyhydroxyalkanoates, PHA, PHB, Secretion, Phasin, Translocation, HlyA, Synthetic biologyBackground
Fossil derived plastics are non-biodegradable and toxic
to the environment. Based on an United States Environ-
mental Protection Agency study in 2011, there was an
increase in non-biodegradable plastic accumulation in
municipal solid waste systems from 0.5% to 12.4% dur-
ing 1960 to 2010 [1]. Alternative means of producing
plastics in large quantities that are both economically
and environmentally friendly have recently gained con-
siderable attention [2].
Replacing traditional plastic with biodegradable plastic
such as polyhydroxyalkanoates (PHAs) can potentially
reduce total waste by up to 20% [3]. PHAs are produced
by a variety of microorganisms as an intercellular storage* Correspondence: charles.miller@usu.edu
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reproduction in any medium, provided the ormedium for energy and carbon and can accumulate up
to 90% of the cell dry weight [4]. PHAs are biodegrad-
able polymers. The biodegradability can range from days
[5] to months [6] with degradation either taking place
extracellularly or intracellularly. Extensive review on
degradation of PHAs can be found in [7,8]. There are
155 different confirmed types of PHA monomer sub-
units, each with varying monomer repeat number and
side groups [9]. Additionally, PHAs have melting tempera-
tures between 50-180°C and crystallinity of 30–70% [10].
Thus, PHAs have a variety of possible applications, that
could replace traditional plastics derived from petroleum
[11]. Some of the possible applications are highlighted in
previous studies [12,13] and include: packaging, medical
uses [14], agricultural uses, and in carbon nanotubes [15].
Polyhydroxybutyrates (PHB) are a short-chain-length
(scl) PHA polyester with between 3–5 carbon monomers
[9]. The production of PHB in recombinant systems suchl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of the phaCAB operon from Ralstonia eutropha (Cup-
riavidus necator) and cloning into pBluescriptSK- to
generate plasmid pBHR68. pBHR68 has been widely used
for recombinant production of PHB in E. coli. The
phaCAB operon is a three-step enzymatic process by
which acetyl-CoA is converted to PHB: phaC (PHA syn-
thase), phaA (β-ketothiolase), and phaB (acetoacetyl-CoA
reductase) [4,16]. After production of PHB, the PHB poly-
mer forms spherical granules with a hydrophobic core and
attached proteins at the surface, including PHA synthase
and phasin, PhaP1 [17-19].
The cost of producing PHAs is approximately US$ 4-6/
kg and one of the major bottlenecks in scaling up
recombinant PHA production systems is the isolation of
the PHAs [12,20]. Current techniques that are used to iso-
late PHB from E. coli are invasive, including mechanical,
chemical, and biological treatments. These techniques
involve lysing the cellular membrane prior to isolation of
the PHBs. There are a variety of methods that have been
suggested for recovery of PHBs from microorganisms and
a detailed review of the different PHB isolation methods is
outlined in [20].
The development of a secretion mechanism eliminates
the need for cell disruption by mechanical or chemical
means, and may lead to continuous (or semi-continuous)
PHB production systems. In gram-negative bacteria like E.
coli, compounds are exported via six major secretory path-
ways [21-24]. Recombinant proteins can be targeted to
type I and II secretory pathways through genetic fusion
with signal peptide targeting sequences.
PHBs are non-proteinaceous polyesters and therefore
cannot be directly targeted for translocation by signal
peptide fusion. Phasins are low-molecular weight pro-
teins that play a role in PHB granule formation by bind-
ing to the PHB granule surface [19,25]. Phasins are
structural proteins found in organisms that naturally
produce PHAs and are similar in function to oleosins
which are found in plants [19,26]. Currently, oleosins
are used to purify various compounds such as pharma-
ceuticals from plants [27].
Translocation of PHBs is possible through optimiza-
tion of granule size, which reportedly varies from 50 to
1,000 kDa based on growth parameters and host strain
[4]. One of the functions of phasin is to increase the
surface-to-volume ratio of granules so that higher accu-
mulation levels can be achieved [25,28,29]. Therefore,
the size of the PHB granule can be decreased signifi-
cantly through phasin overexpression. In one such study,
overexpression of phasin resulted in a decrease of PHB
granules from 70–310 nm diameter to 20–60 nm [28].
Type I secretion is a simple one step secretion system
that can translocate proteins from the cytoplasm to the
extracellular medium without protein interaction withthe periplasm [30]. Proteins of nearly 900 kDa (large
adhesion protein, LapA) have reportedly been secreted
to the extracellular milieu by the type I secretory mechan-
ism of gram-negative bacteria [31,32]. Specifically using
the Hemolysin (HlyA) secretion mechanism proteins such
as β-galactosidase (117 kDa) [33], β-gal-OmpF (56 kDa)
[34], and green fluorescent protein (GFP) (27 kDa) [35]
have been secreted by E. coli. The physical characteristics
of the secretion channel are approximately 3.5 nm in
diameter with a length of 14 nm as reported by Fernández
et al., which makes the secretion phenomena of large pro-
teins very interesting [36].
Our group has previously used a synthetic biological
engineering approach to demonstrate the feasibility of
HlyA, GeneIII, PelB, and TorA secretion systems in E.
coli with the use of GFP [35]. From the aforementioned
study, the type I secretion system using the HlyA signal
peptide yielded the best results for secretion of GFP out-
side of the cell and into the medium [35]. The objective
of this study was to demonstrate that phasin can be used
to secrete PHB from E. coli using type I secretion
machinery.
Results and discussion
Initial studies were carried out to demonstrate expres-
sion and then successful translocation of phasin, PhaP1,
into the extracellular medium. Once this was demon-
strated, PHB secretion experiments were conducted that
included: growth studies, PHB production in secreted
and non-secreted fractions, and visualization with scan-
ning electron microscopy (SEM).
Analysis of phasin translocation
For E. coli cells expressing pCMEL1 and pLG575, a phasin
band is observed at 22–26 kDa in the cytoplasmic frac-
tion, the periplasmic fraction, the membrane fraction, and
the concentrated extracellular media (Figure 1). This poly-
acrylamide gel and corresponding immunoblot demon-
strated: 1) the ability for E. coli to produce non-codon
optimized Phasin (from R. eutropha), a protein not natu-
rally expressed in E. coli and 2) translocation of phasin
into different fractions of the cell. Compared to other
studies that focused non-translocated phasin, the phasin
band sizes in all of the different fractions are similar
[19,29]. Since the translocation of phasin was successful,
secretion of PHB using phasin was then attempted.
Growth studies
The PHB secreting strain consisted of pCMEL3 + pLG575,
whereas the non-secreting strain consisted of pBHR68 +
pLG575. From the CFU/mL vs. time graph (Figure 2)
stationary phase was reached at approximately 8–12 h for
both non-secreting and secreting strains. The non-
secreting and secreting strains had the highest overall
Figure 1 SDS polyacrylamide gel and corresponding immunoblot of subcellular fractions for PhaP1:HlyA. C – cytoplasmic fraction,
P – periplasmic fraction, M – membrane fraction, S – concentrated supernatant (media) fraction. The position of phasin bands varies from
roughly 22–26 kDa.
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respectively, after 12 h. There was no significant difference
between CFU/mL for the non-secreting and secreting
strains after 24 and 48 h (p > 0.05). This statistical analysis
on the CFU/mL demonstrated that there were no signifi-
cant differences in E. coli growth between the two samples
at times when PHB analysis was conducted (24 and 48 h).
Furthermore, this suggests that the secretion of PHB does
not affect cell viability.
PHB production analysis
PHB production analysis was carried out 24 and 48 because
after 24 h the E. coli harboring the plasmid systems were in
stationary phase. Previous studies demonstrated that PHB
did not accumulate to significant levels during the exponen-
tial growth phase. Acetyl-CoA is required for cell synthesis
during the exponential phase but is diverted to produce
PHB in the stationary phase, thus, there is a delay between
carbon source utilization and PHB production [37].
PHB measured inside the cell is defined as the internal
fraction and PHB collected by the CaCl2 precipitation
method is the secreted fraction. 24 h after induction, the in-
ternal fraction of the cells demonstrated PHB productionFigure 2 CFU/mL vs. Time (hours) for secreting and non-secreting str
experiments (one standard deviation shown).for both the secreting and non-secreting strains. While the
non-secreting strain accumulated approximately 41.93 ±
13.5% of PHB in the dry cell weight at 24 h, the secreting
strain accumulated approximately 28.85 ± 0.41% (Table 1).
48 h after induction the non-secreting and secreting strains
had accumulated 47.24 ± 6.0% and 38.80 ± 15.5% PHB,
respectively. There was no significant statistical difference
seen in internally accumulated PHB in either the non-
secreting or secreting strains at 24 and 48 h (p > 0.05) after
induction. The internal levels of PHB accumulation in the
non-secreting and secreting strains are comparable to those
seen in other studies such as [38], where the authors
showed accumulation of 42% PHB in E. coli DH5α harbor-
ing pBHR68 after 24–48 h [38].
PHB secreted fractions were analyzed at 24 and 48 h after
induction for the secreting and non-secreting strains. PHB
harvested in the secreted fraction of the non-secreting
strains was 0.31 ± 0.35% and 0.72 ± 0.89%, respectively.
The PHB present in the secreted phase demonstrated
that some lysed cells containing PHB were found in this
fraction after CaCl2 precipitation. This is to be expected
from a differential centrifugation technique, such as
that used in this study. 24 and 48 h after induction, theains of PHB producing E. coli, averaged from triplicate
Table 1 Production of PHB in secreting (pCMEL3 + pLG575) and non-secreting (pBHR68 + pLG575) strains of E. coli at
24 and 48 h
% mass of PHB in dry mass Production g/L PHB












Non-secreting 24 0.31 ± 0.35 41.93 ± 13.5 0.40 ± 0.27 5.65 ± 1.1 6.05 ± 1.1 0.40 ± 0.07
48 0.72 ± 0.89 47.24 ± 6.0 0.50 ± 0.41 5.43 ± 1.7 5.93 ± 1.8 0.40 ± 0.12
Secreting 24 0.69 ± 0.18 28.85 ± 0.41 0.40 ± 0.06 3.42 ± 0.33 3.82 ± 0.3 0.25 ± 0.02
48 28.29 ± 7.2* 38.80 ± 15.5 2.57 ± 0.75* 4.58 ± 2.47 7.15 ± 2.6 0.48 ± 0.17
*Indicates statistical significance within column (p < 0.05).
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respectively in the secreted fraction. The level of PHB
seen in the secreted fraction of the secreting strain was
statistically significant after 48 h post induction, com-
pared to the non-secreting strain (p < 0.05). This in-
crease in PHB present in the secreted phase after 48 h
indicates that the secretion system is functioning and
producing higher amounts of PHB, with a small
amount of non-secreted PHB ending up in the secreted
fraction. These results demonstrate that PHB secretion
is initiated 24 h after induction.
Secretion of PHB can help in downstream processes by
aiding in PHB separation from biomass. Of the total PHB
produced by the secreting strain after 48 h, 36% was col-
lected in the secreted fraction and the remaining 64% was
in the internal fraction. The secreting strain had a total
PHB production of 7.15 g/L compared to 5.93 g/L for the
non-secreting strain after 48 h post induction.
It has been demonstrated from previous studies that
PHB can accumulate in larger quantities in E. coli when
using a bioreactor compared to a shaker flask. A fed-
batch bioreactor study by Choi et al. 1999, reported
accumulation of up to 77% PHB of dry cell weight [39]
and another study reported accumulation of up to 80%
[37]. Future studies will be performed to determine how
well the secreting strain performs under similar bioreac-
tor growth conditions.Figure 3 SEM images taken from overnight cultures of E. coli XL1Blue
B) pCMEL3 (non-secreting with phasin overexpression), and C) pCMELSEM analysis
SEM is not widely used for PHB analysis since a surface
topographical analysis is typically of little use. SEM has
however been used to visualize PHA granules produced
from recombinant E. coli [40] and PHA degradation
from a variety of organisms [41]. In the case of secretion,
SEM can provide images of what is occurring at the sur-
face of E. coli during the secretion process. Figure 3A
shows a PHB non-secreting E. coli strain harboring the
pBHR68 plasmid. Figure 3B shows E. coli that is accu-
mulating PHB and overexpressing phasin. Figure 3C
shows the full secretion system in E. coli (pCMEL3 +
pLG757). Figure 3C suggests that PHB is being secreted
outside of the bacteria and into the medium. These ob-
servations further demonstrate the functioning of the
PHB secretion system.
The SEM photo in Figure 3C suggests that secretion
of PHB occurs at the polar regions of the cell. Interest-
ingly it has been found in previous studies [42,43] that
PHB granule formation occurs at the cell poles in E. coli
when both phasin and PHB are being produced. When
PHB is being produced the interpretation is that PHA
synthase is active, and it has previously been suggested
that PHA synthase has polar targeting information [43].
It is interesting that E. coli is able to secrete PHB
through pore sizes of 3.5 nm [36] in diameter. From the
results of this this study not all the PHB produced isharboring different plasmid systems: A) pBHR68 (non-secreting),
3 + pLG575 (complete PHB production and secretion system).
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between the secreted and non-secreted PHB.
Conclusions
This study demonstrated the successful expression of
phasin, PhaP1, and its translocation using type I secre-
tion in E. coli. Once translocation of PhaP1 was success-
ful, a recombinant synthetic biological system to secrete
PHBs was designed and tested. Initiation of PHB secre-
tion occurs between 24 and 48 h after induction of PHB
synthesis. Of the total PHB produced by the secreting
strain, 36% was collected in the secreted fraction and
64% remained in the internal fraction after 48 h.
Secretion of PHB should help in downstream process-
ing whereby PHB is separated from the cell mass, which
can aid in PHB recovery and purification. Future studies




Genetic parts were constructed in accordance with the
BioBrick and BioFusion technical standards [44,45].
The BioFusion standard was specifically used to create
phasin and signal peptide parts because this genetic fu-
sion system is compatible with the original BioBrick
standard [45,46].
Descriptions of strains and plasmids used to study
PHB and phasin production and translocation areTable 2 Strains, plasmids, and oligonucleotides used in this s
Strains Relevant characteristics
Strains
BL21-Gold (DE3) E. coli B F– ompT hsdS(rB– mB–) dcm+ TetR
XL1 Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44
Cupriavidus necator H16 Wild type, PHA producing
Plasmids
pLG575 pACYC184 derivative, HlyBD, p15A origin, C
pBHR68 pBluescript SK−, phbCAB genes from R. eu
pSB1AK3 High copy BioBrick vector, pMB1 origin, Am
pSB1A3 High copy BioBrick vector, pMB1 origin, Am
pSB3K3 Medium copy BioBrick standard vector, p1
pCMEL1 phaP1, C-terminal BioFusion with HlyA sign
RBS(BBa_B0034), in pSB1A3
pCMEL2 phaP1, C-terminal BioFusion with HlyA sign
RBS(BBa_B0034), in pSB3K3






g114t_antisense 5′-agtcttgacgacctgaaggttcagctcgacg-3′provided as Table 2. Completed BioBrick parts were
transformed in BL21-Gold (DE3) competent E. coli
(Agilent Technologies, Santa Clara, CA) for protein ex-
pression studies. PHB production and secretion studies
were carried out in E. coli XL1 Blue (Agilent Technolo-
gies, Santa Clara, CA). Plasmid pLG575 includes the
coding regions for proteins HlyB and HlyD [47,48]. Plas-
mids pSB1AK3, pSB1A3, and pSB3K3 are BioBrick
standard vectors for assembly and expression of BioBrick
genetic devices [49].
BioBrick and plasmid construction
All restriction enzymes and related reagents were pur-
chased from Thermo Fisher Scientific Inc. (Glen Burnie,
MD). The signal peptide HlyA was made through syn-
thetic design and construction as mention in Linton et al.
2012 (DNA 2.0, Menlo Park, CA) [35]. A BioFusion-
compatible phasin BioBrick was constructed by isolating
phaP1 from the genomic DNA of R. eutropha using PCR
with primers PhaP1FOR and PhaP1REV that included the
BioFusion prefix and suffix as overhanging ends (Table 2).
The 620 bp PCR product was isolated by gel electrophor-
esis, digested with EcoRI and SpeI, and ligated into
pSB3K3. A PstI site was removed from phaP1 (while
conserving amino acid sequence) using a QuikChange II
Site-Directed Mutagenesis Kit and the QuikChange® Pri-
mer Design Program (Agilent Technologies, Santa Clara,
CA). The designed primers (g114t and g114t_antisense)
for site-directed mutagenesis are shown in Table 2. Thetudy
Reference
gal λ(DE3) endA Hte Agilent technologies




pR and KanR [49]
pR [49]
5A origin, KanR [49]
al peptide, Lac promoter (BBa_R0010), This study
al peptide, Lac promoter (BBa_R0010), This study
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confirmed by sequence analysis.
Step-wise assembly of composite BioBrick devices was pri-
marily carried out in pSB1AK3. Completed devices were sub-
sequently ligated into pSB1A3 and pSB3K3. The lac promoter
(BBa_R0010) and ribosome binding site (BBa_B0034) were
used as described in Linton et al. 2012 [35]. The pCMEL1
plasmid was used for studies on phasin translocation because
its origin of replication (pMB1) was compatible with the ori-
gin of replication of pLG575 (p15A). BL21-Gold (DE3) was
co-transformed with pCMEL1 and pLG575. The pCMEL3
plasmid was used for studies on type I secretion of PHA. The
composite part containing the promoter, RBS, coding region,
and terminator were cloned into pBHR68 from pCMEL2 by
digestion with EcoRI and XhoI. XL1-Blue was co-transformedFigure 4 PHB secretion. A. Schematic for PHB secretion containing dual p
peptide binds to PHB granule surface and the PHB-phasin-signal peptide c
of phaC, phaC, and phaB genes from pBHR68. pCMEL3 also contains the gwith pCMEL3 and pLG575 for PHA secretion studies. A
schematic of the secretion system is presented in Figure 4.
Cellular fractionation and western blotting
Overnight cultures of E. coli BL21-Gold (DE3) harboring
pCMEL1 and pLG575 were used to inoculate (1:100 v/v
dilution) 100 ml of LB media containing 25 μg/ml chlor-
amphenicol (Acros Organics, Fair Lawn, NJ) and 50 μg/ml
ampicillin (IBI Scientific, Peosta, IA) [50]. The lysozyme/
EDTA/osmotic shock and chloroform-based cellular
fractionation procedures and methods for analyzing
supernatant fractions are previously discussed in Linton
et al. 2012 [35]. Briefly, 50 mL of cell culture were
centrifuged and the pellet was resuspended in a buffer and
subjected to osmotic shock. Centrifugation was used tolasmid system pCMEL3 and pLG575. Phasin with attached signal
omplex is targeted for type I secretion. B. pCMEL3 plasmid consisting
enes needed for phasin-HylA production.
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membranes were fractionated via ultracentrifugation.
Approximately 40 μg of protein from each of the
respective fractioned samples were separated using pre-
cast 12% SDS-polyacrylamide tris-glycine gels (Jule Inc.,
Milford, CT). Electrophoresis operating conditions were
used as specified by the manufacturer. Phasin immuno-
blotting was carried out using a PhaP1 specific antibody
[51,52]. An Anti-Rabbit IgG HRP conjugated secondary
antibody was purchased from Promega (Madison, WI).
Respective primary and secondary antibody concentra-
tions of 1:50,000 v/v and 1:2,500 v/v were used.
PHB secretion studies
All secretion studies were carried out in triplicate. Secre-
tion studies were conducted with the secreting system
(pCMEL3 + pLG575 in XL1 Blue) and non-secreting
system (pBHR68 + pLG575 in XL1 Blue). The non-
secreting system does not contain phasin-HlyA.
Media formulation and growth conditions
R. eutropha was cultured following the methods outlined
in Linton et al. 2012 [53]. M9 salts (Becton, Dickinson
and Co, Sparks, MD) supplemented with 1.5% (w/v) glu-
cose (ACS grade, Acros Organics, Fair Lawn, NJ) and
0.2% (w/v) yeast extract (Becton, Dickinson and Co,
Sparks, MD) was used for PHB secretion studies in E.
coli [38]. Overnight E. coli cultures harboring specific
plasmids were inoculated from freezer stocks into 5 ml
of M9 media with chloramphenicol (34 μg/ml), ampicil-
lin (50 μg/ml), and grown in an orbital shaker table at
220 rpm at 37°C. Overnight cultures were then used to
seed larger 250 ml flasks (50 ml media volume) at an
initial optical density (OD600) of 0.05 at time 0 h.
0.1 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG)
(Gold Biotechnology, Inc. St. Louis, MO) was added to
each flask at time 0 h. Flasks were removed at 24, and
48 h and analyzed for PHB. CFU/mL was measured at
time points 0, 4, 6, 8, 12, and 24 h.
Recovery of secreted PHB
PHB granules can agglomerate together naturally and
previous studies have demonstrated the use of Calcium
chloride (CaCl2) to enhance this process. A study by Fidler
et al. used CaCl2 to purify PHB from lysed cells by select-
ively aggregating PHB granules. It was observed that PHB
granules fell to the bottom of the test tube after addition
of CaCl2 [54]. Another CaCl2 method for PHB recovery
by Resch et al. used a low speed centrifugation step to
further enhance PHB recovery from cell debris [55].
In this study, techniques for secreted PHB recovery
were adapted from the methods outlined in [55]. At 24,
and 48 h 0.01 M CaCl2 (final concentration, Avantor
Performance Materials, Inc. Center Valley, PA) was addedto the bacterial culture and mixed by inverting the tube
several times. The tubes were then allowed to sit for 10
mins at room temperature and then centrifuged at 54 × g
for 5 min. The supernatant was removed and transferred
to a fresh tube and the pellet was freeze dried. The super-
natant was centrifuged at 3452 × g for 10 mins and the
pellet was freeze dried. The pellet from the first centrifu-
gation contained secreted PHB with CaCl2 and the pellet
from the second centrifugation contained bacterial mass
and non-secreted PHB. Secretion studies and PHB analy-
sis were conducted in triplicate.
PHB concentration determination
PHB concentrations were determined based on a NMR-
GC method described in Linton et al. 2012 [53]. Briefly,
samples were lyophilized after which approximately
15 mg of sample was mixed with equal volumes of
sodium hypochlorite and deuterated chloroform. Samples
were centrifuged and 1H NMR was carried out on the
PHB fraction. PHB concentration was determined from a
NMR-GC standard.
Scanning electron microscopy (SEM)
To visually show PHB secretion from E. coli, SEM was
performed. SEM protocols were used as mentioned in
[56]. Briefly, secreting and non-secreting strains were
grown up overnight and fixed onto glass cover slips.
Samples were mounted on aluminum stubs and sputter
coated with 10 nm gold. SEM was carried out using a
Hitachi S4000 SEM.
Statistical analysis
All growth (CFU/mL) and PHB yield studies were carried
out in triplicate to show consistency of data. Statistical
analysis was conducted with Statistical Analysis Software
(SAS 9.3, SAS Institute Inc., Cary, NC). A two-way analysis
of variance (ANOVA) with tukey post hoc comparison per-
formed on significant results (confidence level 95%).
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